[1] |
Schneider AS. Triosephosphate isomerase deficiency: historical perspectives and molecular aspects. Baillieres Best Pract Res Clin Haematol, 2000, 13(1): 119-140.
doi: 10.1053/beha.2000.0061
pmid: 10916682
|
[2] |
Rieder SV, Rose IA. The mechanism of the triosephosphate isomerase reaction. J Biol Chem, 1959, 234(5): 1007-1010.
pmid: 13654309
|
[3] |
Wierenga RK, Kapetaniou EG, Venkatesan R. Triosephosphate isomerase: a highly evolved biocatalyst. Cell Mol Life Sci, 2010, 67(23): 3961-3982.
doi: 10.1007/s00018-010-0473-9
pmid: 20694739
|
[4] |
Schneider AS, Valentine WN, Hattori M, Heins HL. Hereditary hemolytic anemia with triosephosphate isomerase deficiency. N Engl J Med, 1965, 272: 229-235.
doi: 10.1056/NEJM196502042720503
|
[5] |
Orosz F, Oláh J, Ovádi J. Triosephosphate isomerase deficiency: new insights into an enigmatic disease. Biochim Biophys Acta, 2009, 1792(12): 1168-1174.
doi: 10.1016/j.bbadis.2009.09.012
pmid: 19786097
|
[6] |
Orosz F, Oláh J, Ovádi J. Triosephosphate isomerase deficiency: facts and doubts. IUBMB Life, 2006, 58(12): 703-715.
doi: 10.1080/15216540601115960
pmid: 17424909
|
[7] |
Daar IO, Artymiuk PJ, Phillips DC, Maquat LE. Human triose-phosphate isomerase deficiency: a single amino acid substitution results in a thermolabile enzyme. Proc Natl Acad Sci USA, 1986, 83(20): 7903-7907.
pmid: 2876430
|
[8] |
Schneider A, Cohen-Solal M. Hematologically important mutations: triosephosphate isomerase. Blood Cells Mol Dis, 1996, 22(1): 82-84.
doi: 10.1006/bcmd.1996.0011
|
[9] |
Oliver C, Timson DJ. In silico prediction of the effects of mutations in the human triose phosphate isomerase gene: towards a predictive framework for TPI deficiency. Eur J Med Genet, 2017, 60(6): 289-298.
doi: S1769-7212(16)30217-8
pmid: 28341520
|
[10] |
Ralser M, Heeren G, Breitenbach M, Lehrach H, Krobitsch S. Triose phosphate isomerase deficiency is caused by altered dimerization--not catalytic inactivity-- of the mutant enzymes. PLoS One, 2006, 1(1): e30.
doi: 10.1371/journal.pone.0000030
|
[11] |
Zhang CX, Liu F. A brief protocol for high-resolution whole mount in situ hybridization in zebrafish. Hereditas(Beijing), 2013, 35(4): 522-528.
|
|
张春霞, 刘峰. 斑马鱼高分辨率整胚原位杂交实验方法与流程. 遗传, 2013, 35(4): 522-528.
|
[12] |
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. Fiji: an open-source platform for biological-image analysis. Nat Methods, 2012, 9(7): 676-682.
doi: 10.1038/nmeth.2019
pmid: 22743772
|
[13] |
Roland BP, Zeccola AM, Larsen SB, Amrich CG, Talsma AD, Stuchul KA, Heroux A, Levitan ES, Vandemark AP, Palladino MJ. Structural and genetic studies demonstrate neurologic dysfunction in triosephosphate isomerase deficiency is associated with impaired synaptic vesicle dynamics. PLoS Genet, 2016, 12(3): e1005941.
doi: 10.1371/journal.pgen.1005941
|
[14] |
Selamioğlu A, Karaca M, Balcı MC, Körbeyli HK, Durmuş A, Yıldız EP, Karaman S, Gökçay GF. Triosephosphate isomerase deficiency: E105D mutation in unrelated patients and review of the literature. Mol Syndromol, 2023, 14(3): 231-238.
|
[15] |
Li XX, Li Y, Zhao X, Peng GX, Li JP, Ye L, Yang WR, Zhou K, Fan HH, Yang Y, Xiong YZ, Li Y, Song L, Jing LP, Zhang L, Zhang FK. Characteristics of bone marrow compensatory erythropoiesis in hereditary spherocytosis. Chin J Hematol, 2022, 43(2): 115-119.
doi: 10.3760/cma.j.issn.0253-2727.2022.02.005
pmid: 35381671
|
|
李小霞, 李园, 赵馨, 彭广新, 李建平, 叶蕾, 杨文睿, 周康, 樊慧慧, 杨洋, 熊佑祯, 李洋, 宋琳, 井丽萍, 张莉, 张凤奎. 遗传性球形红细胞增多症骨髓红系造血代偿特征. 中华血液学杂志, 2022, 43(2): 115-119.
|
[16] |
Beguin Y, Clemons GK, Pootrakul P, Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood, 1993, 81(4): 1067-1076.
pmid: 8427988
|
[17] |
Horwood NJ. Macrophage polarization and bone formation: a review. Clin Rev Allergy Immunol, 2016, 51(1): 79-86.
doi: 10.1007/s12016-015-8519-2
|
[18] |
Segal AW. How neutrophils kill microbes. Annu Rev Immunol, 2005, 23: 197-223.
pmid: 15771570
|
[19] |
Segal J, Mülleder M, Krüger A, Adler T, Scholze-Wittler M, Becker L, Calzada-Wack J, Garrett L, Hölter SM, Rathkolb B, Rozman J, Racz I, Fischer R, Busch DH, Neff F, Klingenspor M, Klopstock T, Grüning NM, Michel S, Lukaszewska-Mcgreal B, Voigt I, Hartmann L, Timmermann B, Lehrach H, Wolf E, Wurst W, Gailus-Durner V, Fuchs H, de Angelis MH, Schrewe H, Yuneva M, Ralser M. Low catalytic activity is insufficient to induce disease pathology in triosephosphate isomerase deficiency. J Inherit Metab Dis, 2019, 42(5): 839-849.
doi: 10.1002/jimd.12105
pmid: 31111503
|
[20] |
Myers TD, Ferguson C, Gliniak E, Homanics GE, Palladino MJ. Murine model of triosephosphate isomerase deficiency with anemia and severe neuromuscular dysfunction. Curr Res Neurobiol, 2022, 3: 100062.
doi: 10.1016/j.crneur.2022.100062
|
[21] |
Hrizo SL, Eicher SL, Myers TD, Mcgrath I, Wodrich APK, Venkatesh H, Manjooran D, Swoger S, Gagnon K, Bruskin M, Lebedev MV, Zheng S, Vitantonio A, Kim S, Lamb ZJ, Vogt A, Ruzhnikov MRZ, Palladino MJ. Identification of protein quality control regulators using a Drosophila model of TPI deficiency. Neurobiol Dis, 2021, 152: 105299.
doi: 10.1016/j.nbd.2021.105299
|
[22] |
Mainfroid V, Terpstra P, Beauregard M, Frère JM, Mande SC, Hol WG, Martial JA, Goraj K. Three hTIM mutants that provide new insights on why TIM is a dimer. J Mol Biol, 1996, 257(2): 441-456.
pmid: 8609635
|
[23] |
Orosz F, Wágner G, Liliom K, Kovács J, Baróti K, Horányi M, Farkas T, Hollán S, Ovádi J. Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules. Proc Natl Acad Sci USA, 2000, 97(3): 1026-1031.
pmid: 10655478
|